Pengaruh Vitamin D terhadap Faktor Metabolik pada Perempuan dengan Sindroma Ovarium Polikisitik (SOPK): Systematic Review - Meta Analysis

Effect of Vitamin D on Metabolic Factors in Women with Polycystic Ovary Syndrome (PCOS): Systematic Review - Meta Analysis

  • Andriana - Andriana Poltekkes Kemenkes Semarang
  • Suharyo Hadisaputro Poltekkes Kemenkes Semarang, Semarang, Indonesia
  • Aris Santjaka Poltekkes Kemenkes Semarang, Semarang, Indonesia
Keywords: Polycystic Ovarian Syndrome, Randomized Controlled Trial, Vitamin D

Abstract

Deficiency of Vitamin D is one of the causes of Polycystic Ovary Syndrome (PCOS). Vitamin D deficiency can affect metabolic factors in women with PCOS. The purpose of this study was to analyze the effect of vitamin D on the metabolic factors of women with PCOS. The method used is the Systematic Review-Meta Analysis study design. The databases used for searching articles are Sciencedirect, PubMed, and Proquest. Keywords combined with Boolean Operators Inclusion criteria: publications with RCT designs from 2015 to 2020, women aged 18 to 49 years with PCOS, type of vitamin D intervention. Outcomes measured were levels of FPG, insulin, triglycerides, total kolesterol, LDL, HDL, and HOMA-IR. The results of the research where 12 studies were analyzed because they met the eligibility criteria. Administration of vitamin D significantly affected total kolesterol (WMD, -7.94; 95% CI, -15.74 to -0.13, P = 0.05), and HDL (WMD, ̶ 3.24; 95% CI, ̶ 4.32 to ̶ 2.16, P < 0.00001). Vitamin D intervention had no significant effect on FPG, insulin, triglycerides, LDL, and HOMA-IR levels. The conclusions from this study stated that Vitamin D influenced total kolesterol and HDL levels.

 

Defisiensi Vitamin D merupakan salah satu penyebab terjadinya Sindrom Ovarium Polikistik (SOPK). Defisiensi vitamin D dapat mempengaruhi faktor-faktor metabolik pada perempuan yang mengalami SOPK. Tujuan penelitian ini untuk menganalisis pengaruh vitamin D terhadap faktor metabolik perempuan dengan SOPK. Metode yang digunakan yaitu Desain studi Systematic Review-Meta Analysis. Database yang digunakan untuk pencarian artikel adalah Sciencedirect, PubMed, dan Proquest. Kata kunci dikombinasikan dengan Boolean Operators Kriteria inklusi: publikasi dengan desain RCT tahun 2015 sampai 2020, perempuan usia 18 sampai 49 tahun dengan SOPK, jenis intervensi vitamin D. Hasil yang diukur adalah kadar FPG, insulin, triglycerides, total kolesterol, LDL, HDL, and HOMA-IR. Hasil penelitiannya adalah 12 studi dianalisis karena memenuhi kriteria kelayakan. Pemberian vitamin D berpengaruh secara signifikan terhadap kadar total kolesterol (WMD, -7.94; 95% CI, -15.74 to -0.13, P = 0.05), dan HDL (WMD, ̶ 3.24; 95% CI, ̶  4.32 to  ̶  2.16, P < 0.00001). Intervensi vitamin D tidak berpengaruh secara signifikan pada kadar FPG, insulin, triglycerides, LDL, dan HOMA-IR. Simpulan dari penelitian ini dinyatakan bahwa Vitamin D berpengaruh terhadap kadar total kolesterol dan HDL.

Downloads

Download data is not yet available.

References

Abootorabi, M. S., Ayremlou, P., Behroozi-lak, T., & Nourisaeidlou, S. (2018). The effect of vitamin D supplementation on insulin resistance , visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome : a randomized placebo-controlled trial. Gynecological Endocrinology, 34(6), 489–494.

Al-Bayyari, N., Al-Domi, H., Zayed, F., Hailat, R., & Eaton, A. (2020). Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial. Clinical Nutrition, 1–33.

Ardabili, H. R., Gargari, B. P., & Farzadi, L. (2012). Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutrition Research, 32(3), 195–201.

Asemi, Z., Foroozanfard, F., Hashemi, T., Bahmani, F., Jamilian, M., & Esmaillzadeh, A. (2015). Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clinical Nutrition, 34(4), 586–592.

Dastorani, M., Aghadavod, E., Mirhosseini, N., Foroozanfard, F., Modarres, S. Z., Siavashani, M. A., & Asemi, Z. (2018). The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reproductive Biology and Endocrinology, 16(94), 1–7.

Foroozanfard, F., Talebi, M., Samimi, M., Mehrabi, S., Badehnoosh, B., Jamilian, M., Maktabi, M., & Asemi, Z. (2017). Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome : A Randomized , Double-Blind , Placebo-Controlled Trial. Hormone and Metabolic Research, 49(8), 612–617.

Franks, S. (2018). Polycystic Ovary Syndrome. Encyclopedia of Endocrine Diseases, 2nd Edition, 1–5.

Fritz, M. A., & Speroff, L. (2011). Clinical Gynecology Endocrinology and Infertility (8th ed.). Lippincott Williams & Wilkins.

Groot, P. C. M. De, Dekkers, O. M., Romijn, J. A., Dieben, S. W. M., & Helmerhorst, F. M. (2011). SOPK , coronary heart disease , stroke and the influence of obesity : a systematic review and meta-analysis. Human Reproduction Update, 17(4), 495–500.

Guducu, N., Gormus, U., Kutay, S. S., Kavak, Z. N., & Dunder, I. (2014). 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome. Gynecol Endocrinol, 30(8), 557–560.

Guraya, S. S., Alhussaini, K. A., Shaqrun, F. M., Alhazmi, B. H., & Alkabli, R. S. (2017). Correlation of clinical, radiological and serum analysis of hypovitaminosis D with polycystic ovary syndrome: A systematic review and meta-analysis. Journal of Taibah University Medical Sciences, 12(4), 277–283.

He, C., Lin, Z., Robb, S. W., & Ezeamama, A. E. (2015). Serum vitamin d levels and polycystic ovary syndrome: A systematic review and meta-analysis. Nutrients, 7(6), 4555–4577.

Hestiantoro, A., Natadisastra, M., Wiweko, B., Sumapraja, K., & Harzif, A. K. (2014). Current updates on Polycystic Ovary Syndrome Endometriosis Adenomyosis. CV Sagung Seto.

Irani, M., Seifer, D. B., Grazi, R. V., Julka, N., Bhatt, D., Kalgi, B., Irani, S., Tal, O., Lambert-Messerlian, G., & Tal, R. (2015). Vitamin D Supplementation Decreases TGF- β1 Bioavailability in SOPK: A Randomized Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism, 100(11), 4307–4314.

Jamilian, M., Foroozanfard, F., Rahmani, E., Talebi, M., Bahmani, F., & Asemi, Z. (2017). Effect of two different doses of vitamin D supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome. Nutrients, 9(12), 1–13.

Javed, Z., Papageorgiou, M., Deshmukh, H., Kilpatrick, E. S., Mann, V., Corless, L., Abouda, G., Rigby, A. S., Atkin, S. L., & Sathyapalan, T. (2019). Supplementation on Cardiovascular Risk Factors , Hormones , and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients, 11(1), 188. https://doi.org/10.3390/nu11010188

Jorde, R., & Figenschau, Y. (2009). Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr, 48, 349–354.

Karamali, M., Ashrafi, M., Razavi, M., Jamilian, M., Kashanian, M., Akbari, M., & Asemi, Z. (2017). The Effects of Calcium , Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D- ­ Deficient Women with Polycystic Ovary Syndrome. Experimental and Clinical Endocrinology & Diabetes, 125(5), 316–321.

Li, H. W. R., Rebecca E. Breretona, Andersona, R. A., Wallace, A. M., & Ho, C. K. M. (2011). Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism, 60(10), 1475–1481.

Macut, D., Bjekic-Macut, J., Rahelic´, D., & Doknic´, M. (2017). Insulin and the polycystic ovary syndrome. Diabetes Research and Clinical Practice, 130, 163–170.

Macut, D., Macut, B.-, & Radojević, A. S.-. (2013). Dyslipidemia and Oxidative Stress in SOPK. Front Horm Res, 40, 51–63.

Maktabi, M., Chamani, M., & Asemi, Z. (2017). The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Hormone and Metabolic Research, 49(7), 493–498.

Miao, C., Fang, X., Chen, Y., & Zhang, Q. (2020). Effect of vitamin D supplementation on polycystic ovary syndrome: A meta‑analysis. Experimental and Therapeutic Medicine, 19, 2641–2649.

Nasri, K., Akrami, S., Rahimi, M., Taghizadeh, M., Behfar, M., Mazandaranian, M. R., Kheiry, A., Memarzadeh, M. R., & Asemi, Z. (2018). The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D- deficient women with polycystic ovary syndrome : A randomized, double-blind, placebo-controlled trial. Endocrine Research, 43(1), 1–10.

Palomba, S. (2018). Infertility in Women with Polycystic Ovary Syndrome Management. Springer International Publishing Switzerland.

Patra, S. K., Nasrat, H., Goswami, B., & Jain, A. (2012). Vitamin D as a predictor of insulin resistance in Polycystic Ovarian Syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 6(3), 146–149.

Rausch, M. E., & Dokras, A. (2012). Polycystic Ovary Syndrome. In S. M. Pfeifer (Ed.), Obstetrics and Gynecology (7th ed., p. 273). Lippincott Williams & Wilkins.

Rocha, M. P., Marcondes, J. A. M., Barcellos, C. R. G., Hayashida, S. A. Y., Curi, D. D. G., Da Fonseca, Â. M., Bagnoli, V. R., & Baracat, E. C. (2011). Dyslipidemia in women with polycystic ovary syndrome: Incidence, pattern and predictors. Gynecological Endocrinology, 27(10), 814–819.

Shojaeian, Z., Sadeghi, R., & Roudsari, R. L. (2019). Calcium and Vitamin D supplementation effects on metabolic factors, menstrual cycles and follicular responses in women with polycystic ovary syndrome: A systematic review and meta-analysis. Caspian Journal of Internal Medicine, 10(4), 359–369.

Sneeringer, R. M., & Wright, K. P. (2018). Polycystic Ovary Syndrome. In S. R. Bayer, M. M. Alper, & A. S. Penzias (Eds.), The Boston IVF Handbook of Infertility (4th ed., p. 149). CRC Press Taylor & Francis Group.

Sung, C., Liao, M., Lu, K., & Wu, C. (2012). Role of Vitamin D in Insulin Resistance. Journal OfBiomedicine and Biotechnology, 2012, 1–11.

Tang, Q., Li, X., Song, P., & Xu, L. (2015). Optimal cut-off values for the homeostasis model assessment of insulin resistance ( HOMA-IR ) and pre-diabetes screening : Developments in research and prospects for the future. Drug Discoveries & Therapeutics, 9(6), 380–385.

Tehrani, F. R., & Behboudi-gandevani, S. (2017). Vitamin D and Human Reproduction. In S. Gowder (Ed.), A Critical Evaluation of Vitamin D: Basic Overview (p. 247). Intech Open.

Thomson, R. L., Spedding, S., & Buckley, J. D. (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical Endocrinology, 77(3), 343–350.

Trummer, C., Schwetz, V., Kollmann, M., Wölfler, M., Münzker, J., Pieber, T. R., Pilz, S., Heijboer, A. C., Obermayer, B., & Elisabeth, P. (2019). Effects of vitamin D supplementation on metabolic and endocrine parameters in SOPK : a randomized-controlled trial. European Journal of Nutrition, 58(5).

Verdoia, M., Schaffer, A., Sartori, C., Barbieri, L., Cassetti, E., Marino, P., Galasso, G., & Luca, G. De. (2014). Vitamin D deficiency is independently associated with the extent of coronary artery disease. Eur J Clin Invest, 44(7), 634–642.

Wang, L., Lv, S., Li, F., Yu, X., Bai, E., & Yang, X. (2020). With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome : A Cross-Sectional Study in Shaanxi China. Frontiers in Endcrinology, 11, 171.

Wehr, E, Pilz, S., Schweighofer, N., Giuliani, A., Kopera, D., Pieber, T. R., & Obermayer-Pietsch, B. (2009). Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. European Journal of Endocrinology, 161, 575–582.

Wehr, Elisabeth, Trummer, O., Giuliani, A., Pieber, T. R., & Obermayer-pietsch, B. (2011). Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. European Journal of Endocrinology, 164(5), 741–749.

Wild, R. A. (2012). Dyslipidemia in SOPK. Steroids, 77(4), 295–299.

Wild, R. A., Rizzo, M., Clifton, S., Ph, D., Carmina, E., & D, M. (2011). Lipid levels in polycystic ovary syndrome : systematic review and meta-analysis. Fertility and Sterility, 95(3), 1073–1079.

Zhang, J., Liu, Y., Liu, X., Xu, L., Zhou, L., Tang, L., Zhuang, J., Guo, W., & Hu, R. (2015). High intake of energy and fat in Southwest Chinese women with SOPK: A population-based case-control study. PLoS ONE, 10(5), 1–13.

Published
2022-10-31
How to Cite
Andriana, A., Hadisaputro, S., & Santjaka, A. (2022). Pengaruh Vitamin D terhadap Faktor Metabolik pada Perempuan dengan Sindroma Ovarium Polikisitik (SOPK): Systematic Review - Meta Analysis. Amalee: Indonesian Journal of Community Research and Engagement, 3(2), 501-515. https://doi.org/10.37680/amalee.v3i2.2759
Abstract views: 396 , PDF (Indonesia) downloads: 482